Hey Michel,
> Alan, Jeremy
> Thanks! What a great analysis! Well substantiated.
> :-)
> So, is it worthwhile to scan through the pathway/reaction databases and
> enumerate which identifiers are being used?
I am inspired by your enthusiasm, and I think that unifying KEGG and
BioCyc compounds would be an excellent use case for us, enabling real
data integration to motivate our BioPAX representation. I spoke with
Peter Karp about this possibility on Friday, and I will be at SRI on
Thursday where we can discuss this further. He may be able to provide
some resources to make this happen.
Sincerely,
Jeremy